A Chinese study describes clinical and genetic differences in young-onset ALS
Original source
Clinical and genetic characteristics of 536 young-onset amyotrophic lateral sclerosis in China: a single-center retrospective study. (opens in a new tab)Compass summarised this from the study's abstract.
Study details
- Studied in
- Human
Population inferred from the title and abstract by Compass.
A single-center study of 536 people in China found that young-onset amyotrophic lateral sclerosis (ALS), defined as symptom onset at or before age 45, generally progressed more slowly than adult-onset ALS. Young-onset cases had fewer bulbar-onset cases, more predominant upper motor neuron features and longer median survival. Rare genetic variants were found in 20% of young-onset patients, with pathogenic or likely pathogenic variants mainly involving SOD1 and FUS.
Why this matters
These findings may help clinicians recognise differences in young-onset ALS and support genetic testing and age-stratified research in this population. The study does not show that genetic testing or any treatment improves outcomes, so it does not change treatment based on these results alone.
Limitations and context
This was a retrospective, single-center study from China involving patients seen between 2014 and 2022. Genetic testing covered 41 established ALS-related genes, and the findings may not apply to all populations. The study shows associations rather than causes or treatment effects.